8-KThe WireRoutine
Bylaw Amendment
Filed Apr 7, 2025 · 1y ago · Accession 0001193125-25-073904
Plain English
Material event — a significant development the company must disclose promptly.
Read the source below for the full document.
Filing details
- Company
- Intellia Therapeutics, Inc.
- Ticker
- NTLA
- CIK
- 1652130
- Form type
- 8-K
- Filing date
- Apr 7, 2025
- Report date
- Apr 3, 2025
- Document
- d901196d8k.htm
- Size
- 283 KB